systemic anti-infective (Anacor)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namesystemic anti-infective (Anacor)
Drug Alias NameNS3 protease inhibitor (Anacor)NS3 protease inhibitor (Anacor)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus (HCV) nonstructural protein 3 inhibitors
TargetsHepatitis C virus (HCV) nonstructural protein 3
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnacor Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcAnacor Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A